Logos Global Management LP

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1792126 San Francisco, CA

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$28,632,000

+$9,226,000 QoQ

Shares Held

2,400,000

+54.8% QoQ

Ownership

1.69%

of shares outstanding

% of Portfolio

1.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Logos Global Management LP holds $1,835,814,678 across 59 Biotechnology names. TRVI ranks #20 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,000,000	$194,500,000
2	ERAS	Erasca, Inc.	11,150,000	$180,407,000
3	IDYA	IDEAYA Biosciences, Inc.	3,450,000	$114,954,000
4	PRAX	Praxis Precision Medicines, Inc.	285,000	$91,824,150
5	CNTA	Centessa Pharmaceuticals plc	2,125,000	$84,405,000
6	TERN	Terns Pharmaceuticals, Inc.	1,500,000	$79,080,000
7	ABVX	Abivax S.A.	675,000	$75,161,250
8	TNGX	Tango Therapeutics, Inc.	3,000,000	$62,760,000

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$28,632,000	2,400,000	+54.8%	Shares	Sole	2026-05-15
2025-12-31	$19,406,000	1,550,000	-29.5%	Shares	Sole	2026-02-17
2025-09-30	$20,130,000	2,200,000	+158.8%	Shares	Sole	2025-11-14
2025-06-30	$4,649,500	850,000	+100.1%	Shares	Sole	2025-08-14
2025-03-31	$2,671,457	424,715	-66.0%	Shares	Sole	2025-05-15
2024-12-31	$5,150,000	1,250,000	-54.5%	Shares	Sole	2025-02-14
2024-09-30	$9,185,000	2,750,000	-1.8%	Shares	Sole	2024-11-14
2024-06-30	$8,344,000	2,800,000	+27.3%	Shares	Sole	2024-08-27
2024-03-31	$7,590,000	2,200,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.